Laurus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LAURUS, and what generic and branded alternatives to LAURUS drugs are available?
LAURUS has seventeen approved drugs.
There are seven tentative approvals on LAURUS drugs.
Summary for Laurus
US Patents: | 0 |
Tradenames: | 13 |
Ingredients: | 13 |
NDAs: | 17 |
Patent Litigation for Laurus: | See patent lawsuits for Laurus |
Drugs and US Patents for Laurus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laurus | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214513-002 | Jan 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Laurus | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214513-001 | Jan 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Laurus | GABAPENTIN | gabapentin | CAPSULE;ORAL | 217546-001 | May 12, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Laurus | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | emtricitabine; tenofovir disoproxil fumarate | TABLET;ORAL | 212114-001 | Jul 26, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Laurus | ABACAVIR SULFATE AND LAMIVUDINE | abacavir sulfate; lamivudine | TABLET;ORAL | 216332-001 | Jul 25, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.